These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1051 related items for PubMed ID: 16778008

  • 1. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA, Chen PE, Wyllie DJ.
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [Abstract] [Full Text] [Related]

  • 2. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M, Marti M, Auberson YP, Morari M.
    J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
    [Abstract] [Full Text] [Related]

  • 3. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K.
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [Abstract] [Full Text] [Related]

  • 4. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ.
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [Abstract] [Full Text] [Related]

  • 5. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM, Chergui K.
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [Abstract] [Full Text] [Related]

  • 6. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL, Larson HC, Morrisett RA, Monaghan DT.
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [Abstract] [Full Text] [Related]

  • 7. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN, Trube G, Kemp JA.
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [Abstract] [Full Text] [Related]

  • 8. Reduced spatial learning in mice treated with NVP-AAM077 through down-regulating neurogenesis.
    Hu M, Sun YJ, Zhou QG, Auberson YP, Chen L, Hu Y, Luo CX, Wu JY, Zhu DY, Li LX.
    Eur J Pharmacol; 2009 Nov 10; 622(1-3):37-44. PubMed ID: 19765576
    [Abstract] [Full Text] [Related]

  • 9. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F, Müller W, Auberson YP, Tricklebank MD, Neijt HC.
    Behav Pharmacol; 2003 Sep 10; 14(5-6):477-87. PubMed ID: 14501261
    [Abstract] [Full Text] [Related]

  • 10. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
    Williams K.
    Mol Pharmacol; 1994 Sep 10; 46(3):531-41. PubMed ID: 7935335
    [Abstract] [Full Text] [Related]

  • 11. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC, Potthoff WK, Aizenman E.
    J Pharmacol Exp Ther; 1999 Nov 10; 291(2):785-92. PubMed ID: 10525101
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T, Laughton P, Myers J, Le Bourdellés B, Kerby J, Whiting PJ.
    Mol Pharmacol; 1995 Nov 10; 48(5):841-8. PubMed ID: 7476914
    [Abstract] [Full Text] [Related]

  • 13. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM, Jane DE, Monaghan DT.
    J Pharmacol Exp Ther; 2000 Mar 10; 292(3):1169-74. PubMed ID: 10688637
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA, Reynolds IJ.
    J Pharmacol Exp Ther; 1999 May 10; 289(2):1041-7. PubMed ID: 10215685
    [Abstract] [Full Text] [Related]

  • 15. Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077.
    Romero-Hernandez A, Furukawa H.
    Mol Pharmacol; 2017 Jul 10; 92(1):22-29. PubMed ID: 28468946
    [Abstract] [Full Text] [Related]

  • 16. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E, Musante V, Neri E, Raiteri M, Pittaluga A.
    J Neurosci Res; 2007 Dec 10; 85(16):3657-65. PubMed ID: 17671992
    [Abstract] [Full Text] [Related]

  • 17. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM, Solís JM.
    Eur J Neurosci; 2006 Jul 10; 24(2):405-18. PubMed ID: 16836643
    [Abstract] [Full Text] [Related]

  • 18. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.
    Mol Pharmacol; 1996 Dec 10; 50(6):1541-50. PubMed ID: 8967976
    [Abstract] [Full Text] [Related]

  • 19. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM, Chergui K.
    J Neurochem; 2008 Aug 10; 106(4):1758-65. PubMed ID: 18540994
    [Abstract] [Full Text] [Related]

  • 20. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L, Cardullo F.
    J Pharmacol Exp Ther; 2010 Dec 10; 335(3):636-44. PubMed ID: 20810618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.